Risk of disease progression in asymptomatic multiple myeloma

Meletios A Dimopoulos; Lia A. Moulopoulos; Terry Smith; Kay Delasalle; Raymond Alexanian

doi:10.1016/0002-9343(93)90120-e

Related publications

Article1998

Prognostic features of asymptomatic multiple myeloma

Donna M. Weber, Meletios A Dimopoulos, Lia A. Moulopoulos, Kay Delasalle, Terry L. Smith, Raymond Alexanian

Article1997

Prognostic features of asymptomatic multiple myeloma

Donna M. Weber, Meletios A Dimopoulos, Lia A. Moulopoulos, Kay Delasalle, Terry Smith, Raymond Alexanian

Article2025

Yearly Assessment of Bone Disease in Patients with Asymptomatic Multiple Myeloma Identifies Early Progression Events and Should Be the Standard Clinical Practice

Ioannis Ntanasis‐Stathopoulos, Vassilis Koutoulidis, Panagiotis Malandrakis, Despina Fotiou, Vasiliki Spiliopoulou, Charalampos Filippatos, Magdalini Migkou, Nikolaos Kanellias, Foteini Theodorakakou, Evangelos Eleutherakis‐Papaiakovou, Efstathios Kastritis, Evangelos Terpos, Meletios A Dimopoulos, Lia A. Moulopoulos, Maria Gavriatopoulou

Article2019

Genomic profiling of smoldering multiple myeloma identifies patients at a high risk of disease progression.

Mark Bustoros, Romanos Sklavenitis‐Pistofidis, Jihye Park, Robert Redd, Binyamin Zhitomirsky, Chip Stewart, Yu‐Tzu Tai, Alex Barbera, François Aguet, Tarek H. Mouhieddine, Selina Chavada, David Soong, Cody J. Boehner, Carl Jannes Neuse, Andrew Dunford, Mahshid Rahmat, Adriana Peilla Glen, Eliezer M. Van Allen, Shaji Kumar, Efstathios Kastritis, Elizabeth A. Morgan, Jacob P. Laubach, Meletios A Dimopoulos,

Article2020

Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression

Mark Bustoros, Romanos Sklavenitis‐Pistofidis, Jihye Park, Robert Redd, Benny Zhitomirsky, Andrew Dunford, Karma Z. Salem, Yu‐Tzu Tai, Shankara Anand, Tarek H. Mouhieddine, Selina J Chavda, Cody J. Boehner, Liudmila Elagina, Carl Jannes Neuse, Justin Cha, Mahshid Rahmat, Amaro Taylor‐Weiner, Eliezer M. Van Allen, Shaji Kumar, Efstathis Kastritis, Ignaty Leshchiner, Elizabeth A. Morgan, Jacob P. Laubach, Tineke Casneuf,

Risk of disease progression in asymptomatic multiple myeloma

Discussion(0)

Related publications

Prognostic features of asymptomatic multiple myeloma

Prognostic features of asymptomatic multiple myeloma

Yearly Assessment of Bone Disease in Patients with Asymptomatic Multiple Myeloma Identifies Early Progression Events and Should Be the Standard Clinical Practice

Genomic profiling of smoldering multiple myeloma identifies patients at a high risk of disease progression.

Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression